published meta-analysis   sensitivity analysis   studies

control in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias hospitalizationdetailed resultsBengu, 2020 (REV) 1.70 [0.03; 87.24] 1.70[0.03; 87.24]Bengu, 2020 (REV)10%113NAnot evaluable new illness compatible with Covid-19 detailed resultsBengu, 2020 (REV) 12.50 [1.30; 120.11] 12.50[1.30; 120.11]Bengu, 2020 (REV)10%113NAnot evaluable0.520.01.0relative treatment effectwww.metaEvidence.org2024-06-14 00:22 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 649,650,589,651,968 - roots T: 290